8-K ·Filed Jun 18, 2026

VTRS

Viatris Inc
NEUTRAL
Impact 3/10
Horizonimmediate Processed3mo ago SEC0001140361-26-025744
8-K material event: Items 1.01
Actionable Insight • Neutral

This refinancing extends Viatris's debt maturity profile and locks in a 4.250% coupon for 7 years. Monitor upcoming quarterly earnings for any changes in leverage ratios or credit rating actions. The euro-denominated issuance introduces modest FX risk but is standard for large-cap pharma.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VTRS ▲ +8.26% at T+60d
NEUTRAL call ✓ call won +8.26% · α vs SPY +6.51% · entry $15.38 → $16.65
Entry anchored
Jun 18, 03:59 PM ET
via exchange tick
T+1d
+2.41%
call +2.41% · α +3.86%
$15.75
settled 3mo ago
T+5d
+6.18%
call +6.18% · α +8.25%
$16.33
settled 3mo ago
T+20d
+12.42%
call +12.42% · α +12.57%
$17.29
settled 2mo ago
T+60d
+8.26%
call +8.26% · α +6.51%
$16.65
settled 17d ago

Price Chart

Loading chart...

Executive Summary

Viatris completed a €650M public offering of 4.250% Senior Notes due 2033, with proceeds used to refinance its $1.675B 3.950% Senior Notes due 2026 via repayment of its revolving credit facility. This is a routine debt refinancing that extends the maturity profile without altering the company's leverage or financial position.

Key Facts

  • €650,000,000 aggregate principal amount of 4.250% Senior Notes due 2033 issued on June 17, 2026.
  • Notes are senior unsecured obligations guaranteed by Mylan Inc., Mylan II B.V., and Utah Acquisition Sub Inc.
  • Net proceeds used to repay amounts drawn under the revolving credit facility in connection with the maturity of $1.675B 3.950% Senior Notes due 2026.
  • Notes mature June 17, 2033, with interest payable annually at 4.250%.
  • Optional redemption at make-whole (T+25bps) prior to April 17, 2033, then at par thereafter.
  • Change of control put at 101% of principal plus accrued interest.

Financial Impact

€650M debt issuance replacing maturing $1.675B notes; no net change in total debt as proceeds refinance existing obligations.

debtinterest expensematurity profile

Risk Factors

  • Currency risk from euro-denominated debt if not hedged.
  • Potential change of control trigger at 101% could accelerate repayment if ownership changes.
  • Refinancing does not address underlying operational or revenue challenges.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (18 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-025744
Document: ef20076340_ex4-2.htm0001140361-26-025744
Document: ef20076340_ex5-2.htm0001140361-26-025744
Document: ef20076340_8k.htm0001140361-26-025744
Document: ef20076340_ex5-3.htm0001140361-26-025744
Document: ef20076340_ex5-1.htm0001140361-26-025744
Document: 0001140361-26-025744-index-headers.html0001140361-26-025744
12 reports for VTRS
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+60▲ +17.24%May 4, 2026
Filters
Rows
Reports for VTRS — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$16.29 $16.94▲ +3.99%▲ +3.39%$17.60 (+8.04%)
Jun 25, 2026
14w ago
144
NEUTRAL ★ 3/10
$16.33 $17.28▲ +5.82%▲ +4.56%$17.60 (+7.78%)
Jun 18, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$15.38 $17.29▲ +12.42%▲ +12.57%$17.60 (+14.43%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$16.04 $16.31▲ +1.68%▲ +1.48%$17.60 (+9.73%)
May 13, 2026
20w ago
Court Ruling
BULLISH ★ 7/10
$17.37 $16.31▼ −6.10%▼ −5.49%$17.60 (+1.32%)
May 7, 2026
21w ago
8-K
BULLISH ★ 7/10
$17.39 $15.56▼ −10.52%▼ −13.66%$17.60 (+1.21%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$15.52 $15.69▲ +1.10%▼ −3.86%$17.60 (+13.40%)
May 4, 2026
21w ago
Court Ruling
NEUTRAL ★ 2/10
$15.20 $15.69▲ +3.22%▼ −2.56%$17.60 (+15.79%)
May 4, 2026
21w ago
Court Ruling
BULLISH ★ 4/10
$15.20 $15.69▲ +3.22%▼ −2.56%$17.60 (+15.79%)
Apr 13, 2026
24w ago
Court Ruling
MIXED ★ 6/10
$13.83 $16.92▲ +22.34%▲ +14.59%$17.60 (+27.26%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access